HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Normalization of the tumor marker CA-125 after oophorectomy in a patient with paraneoplastic cerebellar degeneration without detectable cancer.

Abstract
A 61-year-old woman developed severe subacute cerebellar degeneration in association with a neuronal antinuclear autoantibody. Neurologic investigations were remarkable only for mild CSF leukocytosis. Despite no radiographic evidence of cancer, a salpingo-oophorectomy was performed on the basis of an increased gynecologic cancer marker (CA-125) and the neurologic symptoms that were strongly suggestive of paraneoplastic cerebellar degeneration. Although no tumor was detected in the surgical specimen, CA-125 levels normalized after surgery. The patient remains stable 12 months after surgery with a severe cerebellar syndrome, no evidence of cancer, and persistent circulating antineuronal autoantibodies. An elevated tumor marker in a patient with a presumed paraneoplastic neurologic disorder should suffice as evidence of an occult neoplasm, and guide definitive treatment.
AuthorsW P Mason, J Dalmau, J P Curtin, J B Posner
JournalGynecologic oncology (Gynecol Oncol) Vol. 65 Issue 1 Pg. 173-6 (Apr 1997) ISSN: 0090-8258 [Print] United States
PMID9103409 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • Biomarkers, Tumor
  • CA-125 Antigen
Topics
  • Autoantibodies (blood)
  • Biomarkers, Tumor (blood)
  • CA-125 Antigen (blood)
  • Cerebellar Diseases (blood)
  • Female
  • Humans
  • Middle Aged
  • Ovariectomy
  • Ovary (pathology, surgery)
  • Paraneoplastic Syndromes (blood)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: